Gonadotrophin-release upon iv-administration of a long-acting analogue of luteinizing hormone-releasing hormone in male patients with elevated serum estradiol-concentrations due to chronic liver disease.
The response of LH and FSH upon the administration of D-Ser-(TBU)6-EA10-LH-RH, an analogue of luteinizing hormone-releasing hormone (LH-RH) with prolonged action was evaluated in 6 male patients with increased serum-concentrations of estradiol (E2) due to chronic liver disease. When compared to healthy, male controls (n = 7) basal levels of LH and FSH as well as the secretory response of both gonadotrophins upon the administration of the LH-RH-analogue were larger in patients with chronic liver disease although the qualitative pattern of response was identical with that observed in healthy males. It is concluded that elevated serum-concentrations of E2 in patients with chronic liver disease do not induce qualitative changes in the secretory response of gonadotrophins following the administration of D-Ser-(TBU)6-EA-10-LH-RH.